Literature DB >> 28691668

Correct information to patients undergoing breast-conserving surgery: the medicolegal significance.

A Sanguinetti, A Polistena, R Luchini, M Monacelli, S Avenia, S Galasse, R Cirocchi, N Avenia.   

Abstract

Many of the women newly diagnosed with breast cancer not have access to all the information they need to make the surgical and treatment choices that are most appropriate for them. Research clearly shows that lumpectomy and other breast-conserving surgeries are just as safe as mastectomy for most women with early stage disease, and yet approximately half will undergo the more disfiguring procedures, but many healthy women who have strong family histories of breast cancer consider prophylactic mastectomies, and their decisions are also based on very limited information, because there are few studies showing the effectiveness of that procedure. This paper delineates how to avoid limited information and biased recommendations is important for a conscious and informed choice by the patients.

Entities:  

Mesh:

Year:  2017        PMID: 28691668      PMCID: PMC5509385          DOI: 10.11138/gchir/2017.38.2.061

Source DB:  PubMed          Journal:  G Chir        ISSN: 0391-9005


  21 in total

1.  A field block for breast cancer surgery: technical aspects and a pilot study.

Authors:  Patricia M Riezebos; Marc M Snoeck; Henry J Kleine Koerkamp; Luc J Strobbe
Journal:  Breast J       Date:  2011-08-15       Impact factor: 2.431

2.  Initial clinical experience with multilumen brachytherapy catheters for accelerated partial breast irradiation.

Authors:  Chirag Shah; Mihai Ghilezan; Douglas Arthur; John B Wilkinson; Martin Keisch; Peter Chen; Frank A Vicini
Journal:  Brachytherapy       Date:  2011-12-20       Impact factor: 2.362

3.  Use of breast-conserving surgery for treatment of stage I and stage II breast cancer.

Authors:  E Guadagnoli; J C Weeks; C L Shapiro; J H Gurwitz; C Borbas; S B Soumerai
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

4.  Long-term results of targeted intraoperative radiotherapy (Targit) boost during breast-conserving surgery.

Authors:  Jayant S Vaidya; Michael Baum; Jeffrey S Tobias; Frederik Wenz; Samuele Massarut; Mohammed Keshtgar; Basil Hilaris; Christobel Saunders; Norman R Williams; Chris Brew-Graves; Tammy Corica; Mario Roncadin; Uta Kraus-Tiefenbacher; Marc Sütterlin; Max Bulsara; David Joseph
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-15       Impact factor: 7.038

Review 5.  Multidisciplinary care for patients with breast cancer.

Authors:  Melissa C Hulvat; Nora M Hansen; Jacqueline S Jeruss
Journal:  Surg Clin North Am       Date:  2009-02       Impact factor: 2.741

6.  Are modified radical mastectomies done for T1 breast cancers because of surgeon's advice or patient's choice?

Authors:  B B Tarbox; J K Rockwood; C M Abernathy
Journal:  Am J Surg       Date:  1992-11       Impact factor: 2.565

Review 7.  Systemic lupus erythematosus and breast cancer.

Authors:  Michalis Kontos; Ian S Fentiman
Journal:  Breast J       Date:  2008 Jan-Feb       Impact factor: 2.431

8.  Neo adjuvant Tamoxifen in post menopausal patients with operable breast cancer.

Authors:  R J Salmon; Y Remvikos; F Campana; O Languille; H Magdalenat; B Asselain; K B Clough
Journal:  Eur J Surg Oncol       Date:  2003-12       Impact factor: 4.424

9.  Oncoplastic approaches to breast conservation.

Authors:  Dennis R Holmes; Wesley Schooler; Robina Smith
Journal:  Int J Breast Cancer       Date:  2011-08-22

10.  Ischemic heart disease after breast cancer radiotherapy.

Authors:  Jayant S Vaidya; Max Bulsara; Frederik Wenz
Journal:  N Engl J Med       Date:  2013-06-27       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.